We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · October 28, 2019

Impact of Concomitant Corticosteroids and Anti–PD-1 Treatment

Journal of Oncology Pharmacy Practice

 

Additional Info

Journal of Oncology Pharmacy Practice
The Impact of Corticosteroid Use During Anti-PD1 Treatment
J Oncol Pharm Pract 2019 Sep 07;[EPub Ahead of Print], EY Pan, MY Merl, K Lin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading